Independent of 5-HT1A receptors, neurons in the paraventricular hypothalamus mediate ACTH responses from MDMA

Neuroscience Letters

Volumn 555, Issue , 2013, Pages 42-46

  Zaretsky, Dmitry V ^a   Zaretskaia, Maria V ^a   DiMicco, Joseph A ^b   Durant, Pamela J ^a   Ross, Christian T ^a   Rusyniak, Daniel E ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pharmacology and Toxicology ^*  (United States)

Author keywords

Adrenocorticotropic hormone; Amphetamine; MDMA; Paraventricular hypothalamus; Serotonin 1a receptors

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CORTICOTROPIN; MUSCIMOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; AMPHETAMINE; N (2 (4 (2 METHOXYPHENYL) 1 PIPERAZINYL)ETHYL) N (2 PYRIDINYL)CYCLOHEXANECARBOXAMIDE; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 ANTAGONIST; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; HYPOTHALAMUS; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STRESS; 3,4-METHYLENEDIOXYMETHAMPHETAMINE; 5-HT1A; ACSF; ADRENOCORTICOTROPIN RELEASING HORMONE; ANIMAL; BLOOD; CEREBROSPINAL FLUID SUBSTITUTE; DRUG EFFECT; HPA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMIC-PITUITARY-ADRENAL AXIS; METABOLISM; MICROINJECTION; PARAVENTRICULAR HYPOTHALAMUS; PHYSIOLOGY; PVH; SEROTONIN 1A RECEPTORS; SEROTONIN-1A RECEPTORS; SPRAGUE DAWLEY RAT; WAY; WAY-100635; DRUG EFFECTS;

3,4-METHYLENEDIOXYMETHAMPHETAMINE; 5-HT1A; ACSF; ACTH; ADRENOCORTICOTROPIC HORMONE; ADRENOCORTICOTROPIN RELEASING HORMONE; AMPHETAMINE; ARTIFICIAL CEREBROSPINAL FLUID; HPA; HYPOTHALAMIC-PITUITARY-ADRENAL AXIS; MDMA; PARAVENTRICULAR HYPOTHALAMUS; PVH; SEROTONIN 1A RECEPTORS; SEROTONIN-1A RECEPTORS; WAY; WAY-100635;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; MALE; MICROINJECTIONS; MUSCIMOL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SEROTONIN AGENTS;

EID: 84885040631     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.07.053     Document Type: Article

References (44)

1. Bailey T.W., DiMicco J.A. Chemical stimulation of the dorsomedial hypothalamus elevates plasma ACTH in conscious rats. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2001, 280:R8-R15.
2. Bluet Pajot M.T., Mounier F., di Sciullo A., Schmidt B., Kordon C. Differential sites of action of 8OHDPAT, a 5HT1A agonist, on ACTH and PRL secretion in the rat. Neuroendocrinology 1995, 61:159-166.
3. Calogero A.E., Bagdy G., Szemeredi K., Tartaglia M.E., Gold P.W., Chrousos G.P. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 1990, 126:1888-1894.
4. Clifford E.M., Gartside S.E., Umbers V., Cowen P.J., Hajós M., Sharp T. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo. British Journal of Pharmacology 1998, 124:206-212.
5. DiMicco J.A., Samuels B.C., Zaretskaia M.V., Zaretsky D.V. The dorsomedial hypothalamus and the response to stress: part renaissance, part revolution. Pharmacology Biochemistry and Behavior 2002, 71:469-480.
6. Faure C., Mnie-Filali O., Scarna H., Debonnel G., Haddjeri N. Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT. Neuroscience Letters 2006, 404:122-126.
7. Fernandez F., Aguerre S., Mormède P., Chaouloff F. Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats. European Journal of Neuroscience 2002, 16:607-618.
8. Gerra G., Bassignana S., Zaimovic A., Moi G., Bussandri M., Caccavari R., Brambilla F., Molina E. Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity. Psychiatry Research 2003, 120:115-124.
9. Gray T.S., Carney M.E., Magnuson D.J. Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 1989, 50:433-446.
10. Green A.R., Gabrielsson J., Marsden C.A., Fone K.C. MDMA: on the translation from rodent to human dosing. Psychopharmacology (Berl.) 2009, 204:375-378.
11. Grob C.S., Poland R.E., Chang L., Ernst T. Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations. Behavioural Brain Research 1996, 73:103-107.
12. Gudelsky G.A., Yamamoto B.K. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopamineric, serotonergic and cholinergic neurons. Pharmacology Biochemistry and Behavior 2007, 90:198-207.
13. Guilloux J.P., David D.J., Guiard B.P., Chenu F., Repérant C., Toth M., Bourin M., Gardier A.M. Blockade of 5-HT1A receptors by (±)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology 2006, 31:2162-2172.
14. Hargreaves G.A., Hunt G.E., Cornish J.L., McGregor I.S. High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced Fos expression in a region-specific manner. Neuroscience 2007, 145:764-774.
15. Herin D.V., Liu S., Ullrich T., Rice K.C., Cunningham K.A. Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology (Berl.) 2005, 178:505-513.
16. Hewitt S.A., Bains J.S. Brain-derived neurotrophic factor silences GABA synapses onto hypothalamic neuroendocrine cells through a postsynaptic dynamin-mediated mechanism. Journal of Neurophysiology 2006, 95:2193-2198.
17. Hjorth S., Carlsson A. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?. European Journal of Pharmacology 1986, 129:131-138.
18. Hofmann C.E., Ellis L., Yu W.K., Weinberg J. Hypothalamic-pituitary-adrenal responses to 5-HT1A and 5-HT2A/C agonists are differentially altered in female and male rats prenatally exposed to ethanol. Alcoholism, Clinical and Experimental Research 2007, 31:345-355.
19. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. Journal of Affective Disorders 2001, 62:77-91.
20. Itoi K., Suda T., Tozawa F., Dobashi I., Ohmori N., Sakai Y., Abe K., Demura H. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology 1994, 135:2177-2182.
21. Jorgensen H., Kjaer A., Warberg J., Knigge U. Differential effect of serotonin 5-HT(1A) receptor antagonists on the secretion of corticotropin and prolactin. Neuroendocrinology 2001, 73:322-333.
22. Jorgensen H., Knigge U., Kjaer A., Vadsholt T., Warberg J. Serotonergic involvement in stress-induced ACTH release. Brain Research 1998, 811:10-20.
23. Jorgensen H.S. Studies on the neuroendocrine role of serotonin. Danish Medical Bulletin 2007, 54:266-288.
24. Lennard D.E., Eckert W.A., Merchenthaler I. Corticotropin-releasing hormone neurons in the paraventricular nucleus project to the external zone of the median eminence: a study combining retrograde labeling with immunocytochemistry. Journal of Neuroendocrinology 1993, 5:175-181.
25. Marona-Lewicka D., Nichols D.E. Potential serotonin 5-HT(1A) and dopamine D(4) receptor modulation of the discriminative stimulus effects of amphetamine in rats. Behavioural Pharmacology 2011, 22:508-515.
26. Matthews A.J., Bruno R. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers. Neuropsychobiology 2010, 61:215-222.
27. Moldow R.L., Fischman A.J. Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides 1987, 8:819-822.
28. Myers B., Mark Dolgas C., Kasckow J., Cullinan W.E., Herman J.P. Central stress-integrative circuits: forebrain glutamatergic and GABAergic projections to the dorsomedial hypothalamus, medial preoptic area, and bed nucleus of the stria terminalis. Brain Structure and Function 2013, 10.1007/s00429-013-0566-y.
29. Nash J.F., Meltzer H.Y., Gudelsky G.A. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. Journal of Pharmacology and Experimental Therapeutics 1988, 245:873-879.
30. Ootsuka Y., Nalivaiko E., Blessing W.W. Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, Ecstasy) and its reversal by clozapine. Brain Research 2004, 1014:34-44.
31. Osei-Owusu P., James A., Crane J., Scrogin K.E. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. Journal of Pharmacology and Experimental Therapeutics 2005, 313:1324-1330.
32. Pan L., Gilbert F. Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat. Neuroendocrinology 1992, 56:797-802.
33. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, New York.
34. Rittenhouse P.A., Bakkum E.A., Levy A.D., Li Q., Carnes M., van de Kar L.D. Evidence that ACTH secretion is regulated by serotonin2A/2C (5-HT2A/2C) receptors. Journal of Pharmacology and Experimental Therapeutics 1994, 271:1647-1655.
35. Rusyniak D.E., Zaretskaia M.V., Zaretsky D.V., DiMicco J.A. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors. Journal of Pharmacology and Experimental Therapeutics 2007, 323:477-487.
36. Rusyniak D.E., Zaretskaia M.V., Zaretsky D.V., DiMicco J.A. Microinjection of muscimol into the dorsomedial hypothalamus suppresses MDMA-evoked sympathetic and behavioral responses. Brain Research 2008, 1226:116-123.
37. Sawchenko P.E., Swanson L.W. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. Journal of Comparative Neurology 1983, 218:121-144.
38. Sprague J.E., Banks M.L., Cook V.J., Mills E.M. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). Journal of Pharmacology and Experimental Therapeutics 2003, 305:159-166.
39. Sprouse J., Braselton J., Reynolds L. 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus. Biological Psychiatry 2000, 47:1050-1055.
40. Stotz-Potter E.H., Morin S.M., DiMicco J.A. Effect of microinjection of muscimol into the dorsomedial or paraventricular hypothalamic nucleus on air stress-induced neuroendocrine and cardiovascular changes in rats. Brain Research 1996, 742:219-224.
41. Vicentic A., Li Q., Battaglia G., Van de Kar L.D. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. European Journal of Pharmacology 1998, 346:261-266.
42. Wozniak K.M., Aulakh C.S., Hill J.L., Murphy D.L. The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacology Biochemistry and Behavior 1988, 30:451-456.
43. Zaretskaia M.V., Zaretsky D.V., Shekhar A., DiMicco J.A. Chemical stimulation of the dorsomedial hypothalamus evokes non-shivering thermogenesis in anesthetized rats. Brain Research 2002, 928:113-125.
44. Zaretsky D.V., Zaretskaia M.V., Rusyniak D.E., DiMicco J.A. Stress-free microinjections in conscious rats. Journal of Neuroscience Methods 2011, 199:199-207.